JSH BIOTECH ApS: Financial statements 2023
CVR: 25220129
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
JSH BIOTECH ApS (CVR 25220129) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 300,652 and a net result of DKK -1,323,153 compared with DKK -3,254,998 the year before. That is a decrease of 11.8% compared with the year before. Equity in the 2023 report amounted to DKK 2,340,275. The solvency ratio was 41.9%.
- Gross Profit
- DKK 300,652
- Profit/Loss
- DKK -1,323,153
- Equity
- DKK 2,340,275
- Total Assets
- DKK 5,588,405
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 301 t. | -1.3 mio. | 2.3 mio. | - |
| 2022 | - | 341 t. | -3.3 mio. | 3.8 mio. | - |
| 2021 | - | 649 t. | 3.1 mio. | 7.2 mio. | - |
| 2020 | - | 578 t. | 3.2 mio. | 4.2 mio. | - |
| 2019 | - | 266 t. | 438 t. | 992 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
JSH BIOTECH ApS has published its annual report for 2022. Gross profit came to DKK 340,943, and the net result was DKK -3,254,998.
About JSH BIOTECH ApS
JSH BIOTECH ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named VICH 5941 ApS. The management consists of John Sørensen Haurum. The company is owned by John Sørensen Haurum. In 2025, the company reported a gross profit of DKK 620,332 and a net result of DKK 3,409,861 compared with DKK 1,154,367 the year before. Equity in the 2025 report amounted to DKK 6,651,503.